NEWS RELEASES

Search all of our news releases here.

Try these: Jeff GalvinC. David PauzaHIVFDAAmerican Gene Technologies

American Gene Technologies announces that Chief Science Officer C. David Pauza, Ph.D., will present at the upcoming Cell & Gene Meeting on the Mesa

AGT CSO, David Pauza, to Present HIV cure data At The Cell & Gene Meeting on the Mesa

Sep 29, 2017

ROCKVILLE, MD., September. 26, 2017 (GLOBE NEWSWIRE) — American Gene Technologies International Inc. (AGT), a gene technology company focusing on a lentiviral delivery platform, today announced that Chief Science Officer C. David Pauza, Ph.D., will present at the upcoming Cell & Gene Meeting on the Mesa…

Read More
AGT Builds Montgomery County Gene & Cell Therapy Momentum

AGT Builds Montgomery County Gene & Cell Therapy Momentum

Sep 25, 2017

Fast Growing Maryland Biotech Company Moves to a 24,000 Sq. Ft. Location and Will Host Ribbon Cutting Ceremony on October 23, 2017. September 25, 2017. Montgomery County, MD: American Gene Technologies (AGT), a private Maryland biotechnology company developing cures and treatments for Infectious diseases, cancers and monogenic disorders,…

Read More
Julia R. Brown has been appointed to the board of directors

American Gene Technologies Inc. Appoints Julia R. Brown to its Board of Directors

Sep 11, 2017

ROCKVILLE, Md., Sept. 11, 2017 (GLOBE NEWSWIRE) – American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company with a broad and robust lentiviral drug-development platform, today announced the appointment of Julia R. Brown to its board of directors. Jeffrey A. Galvin…

Read More
American Gene Technologies announces that its CEO, Jeff Galvin, is presenting at the upcoming BIO International Convention

AGT’s CEO to Present at the 2017 BIO International Convention

Jun 7, 2017

ROCKVILLE, MD, June 07, 2017 American Gene Technologies International Inc. (AGT), a genetic medicine company with a broad, robust lentiviral delivery platform, announced today that its CEO, Jeff Galvin, is presenting at the upcoming BIO International Convention. The Convention is being held on June 19-22,…

Read More
AGT CEO Jeff Galvin to Present at HIMSS Precision Medicine Summit

AGT CEO, Jeff Galvin, to Present at HIMSS Precision Medicine Summit

May 31, 2017

ROCKVILLE, MD, May 31, 2017 – American Gene Technologies International Inc. (AGT), a gene technology company with a broad and robust lentiviral delivery platform, today announced that Jeff Galvin, CEO, will present at the upcoming Health Information Management System Society (HIMSS) Precision Medicine Summit, being…

Read More
C. Neil Lyons Appointed as Chief Financial Officer

American Gene Technologies Announces Appointment of C. Neil Lyons as Chief Financial Officer

Apr 12, 2017

Rockville, Maryland, April 12, 2017 American Gene Technologies International Inc. (AGT), a genetic drug development company, announced the appointment of C. Neil Lyons as Executive Vice President and Chief Financial Officer.   Mr. Lyons joins AGT with over a decade of experience leading finance for clinical-stage,…

Read More
American Gene Technologies Announces Collaboration With GeoVax for HIV Cure

American Gene Technologies Announces Collaboration with GeoVax for HIV cure

Mar 14, 2017

Clinical Trial Expected to Commence in 2017   Rockville, MD, March 14, 2017 American Gene Technologies International Inc. (“AGT“) – announced today its collaboration with GeoVax Labs, Inc. (OTCQB: GOVX) for the conduct of a Phase 1 clinical trial investigating AGT’s viral vector technology as a functional…

Read More
American Gene Technologies announces that the CEO, Jeff Galvin is presenting at the upcoming BIO CEO & Investor conference

AGT’s CEO to Present at the 19th BIO CEO & Investor Conference

Feb 3, 2017

Rockville, MD American Gene Technologies (AGT), a gene technology company with a broad, robust lentiviral delivery platform, announced today that the CEO, Jeff Galvin is presenting at the upcoming BIO CEO & Investor conference. The Conference is being held on February 13 -14, at the…

Read More
Jeff Galvin to present at NobleCon13

AGT’s CEO to Present at NobleCon13

Jan 27, 2017

View: 1.27.16 Press Release – NobleCon13 View: Noble Conference – Investor Presentation View: Webcast

Read More
American Gene Technologies announces the appointment of Dr. John J. Rossi, PhD as a collaborator on gene therapy research

Internationally Recognized Molecular Researcher Joins American Gene Technologies as Collaborator

Oct 4, 2016

ROCKVILLE, MARYLAND (October 4, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Dr. John J. Rossi, PhD as a collaborator on gene therapy research. Dr. Rossi is a leader in the field of molecular biology and a pioneer in the…

Read More

Subscribe to News Releases and News Updates

Subscribe to our news release and published article updates to be notified when we release new content!

Follow AGT on Social Media

AGT on Facebook

Exciting news for the future of medicine! The strategic market insight company Nova 1 values the cell & gene therapy market @ $18 billion in 2023 growing at a CAGR of 18% over the next decade. They see a near $100 billion market size by 2033.loom.ly/kpuPhu4#genetherapy #futureofmedicine ... See MoreSee Less
View on Facebook
This #NYHAAD, we support NYHAAD and their mission to create meaningful and intentional spaces for young people to ask questions, learn, and talk about the impacts of HIV and their community. #StopHIVTogether #EndHIVStigma ... See MoreSee Less
View on Facebook
Listen in with Dr. Marcus Conant as he discusses #genetherapy for HIV suppression with CGTLive here loom.ly/zllWHkQ ... See MoreSee Less
View on Facebook
We are grateful to have Dr. Marcus Conant represent our mission to find a functional cure for #HIV, especially at #CROI2024. Learn about his journey in @PharmaVoice: loom.ly/JV88YD0 ... See MoreSee Less
View on Facebook